- |||||||||| Trial completion date, Trial termination, Trial primary completion date: Viral and Host Factors in the Transmission and Pathogenesis of HIV (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=600, Terminated, Trial completion date: Jul 2019 --> Mar 2019 | Recruiting --> Terminated | Trial primary completion date: Jul 2019 --> Mar 2019; Blood drawing protocol for RUH/ADARC. ADARC ceasing operations at RUH
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Safer Sex Program for Young African-American Men (clinicaltrials.gov) - Feb 21, 2019
P2, N=620, Completed, Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> May 2016 | Trial primary completion date: Aug 2018 --> May 2016 Recruiting --> Completed | Trial completion date: May 2019 --> Apr 2018 | Trial primary completion date: May 2018 --> Nov 2017
- |||||||||| Phase classification: HAPI: Healthy Activities for Prize Incentives (clinicaltrials.gov) - Dec 26, 2018
P=N/A, N=75, Completed, Active, not recruiting --> Completed | Trial completion date: Oct 2018 --> Dec 2017 | Trial primary completion date: Nov 2017 --> Feb 2017 Phase classification: P1 --> P=N/A
- |||||||||| Eyevinal (ibudilast) / MediciNova
Trial completion, Trial completion date: IBUD ph II: Trial of Ibudilast for Methamphetamine Dependence (clinicaltrials.gov) - Nov 15, 2018 P2, N=140, Completed, N=13 --> 0 | Recruiting --> Withdrawn Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2017
- |||||||||| Trial primary completion date: Lactoferrin Treatment in HIV Patients (clinicaltrials.gov) - Sep 18, 2018
P2, N=55, Completed, Phase classification: P3 --> P=N/A Trial primary completion date: Dec 2016 --> Jul 2017
- |||||||||| Isentress (raltegravir) / Merck (MSD)
Trial completion: Raltegravir in the Swiss HIV Cohort Study (clinicaltrials.gov) - Jun 6, 2018 P=N/A, N=200, Completed, Trial completion date: Apr 2018 --> Jun 2018 | Trial primary completion date: Apr 2018 --> Jun 2018 Recruiting --> Completed
|